This Union Pacific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Getty Images Holdings ( NYSE:GETY ) , Cogent Comms Hldgs ( NASDAQ:CCOI )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Jefferies analyst Samad Samana downgraded Open Text Corporation OTEX from Buy to Hold and cut ...
Lantheus ( LNTH ) Q2 Revenue Falls 4%
Lantheus ( NASDAQ:LNTH ) , a developer of diagnostic and therapeutic radiopharmaceuticals, reported results on August 6, 2025, for Q2 FY2025. In its latest release, the company missed both GAAP revenue and non-GAAP earnings estimates.-reporting GAAP revenue of $378.0 million versus analyst ...
Nasdaq Surges 1%; Uber Sales Top Estimates - Ainos ( NASDAQ:AIMD ) , Astera Labs ( NASDAQ:ALAB )
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Wednesday. The Dow traded up 0.30% to 44,242.05 while the NASDAQ gained 1.03% to 21,132.45. The S&P 500 also rose, gaining, 0.72% to 6,344.65. Consumer staples shares jumped by 1.3% on Wednesday.
US Stocks Edge Higher; McDonald's Posts Upbeat Earnings - Ainos ( NASDAQ:AIMD ) , Fractyl Health ( NASDAQ:GUTS )
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 0.2% on Wednesday. Following the market opening Wednesday, the Dow traded up 0.04% to 44,131.06 while the NASDAQ gained 0.21% to 20,961.22. The S&P 500 also rose, gaining, 0.12% to 6,306.51.
Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent - Lantheus Holdings ( NASDAQ:LNTH )
Designed to expand PSMA PET imaging access for patients by increasing batch size by ~50% and enhancing supply resilience PDUFA date set for March 6, 2026
Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent
Designed to expand PSMA PET imaging access for patients by increasing batch size by ~50% and enhancing supply resiliencePDUFA date set for March ...
Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time - Lantheus Holdings ( NASDAQ:LNTH )
BEDFORD, Mass., July 23, 2025 ( GLOBE NEWSWIRE ) -- Lantheus Holdings, Inc. ( the "Company" ) LNTH today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, August 6, 2025, to discuss its financial results and provide a business update for the second quarter of ...
Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D
BEDFORD, Mass., July 22, 2025 ( GLOBE NEWSWIRE ) -- Lantheus Holdings, Inc. ( "Lantheus" or the "Company" ) ( NASDAQ: LNTH ) , today announced the successful completion of its previously disclosed acquisition of Life Molecular Imaging Ltd. ( "Life Molecular" ) , a subsidiary of Life Healthcare ...
Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D - Lantheus Holdings ( NASDAQ:LNTH )
BEDFORD, Mass., July 22, 2025 ( GLOBE NEWSWIRE ) -- Lantheus Holdings, Inc. ( "Lantheus" or the "Company" ) LNTH, today announced the successful completion of its previously disclosed acquisition of Life Molecular Imaging Ltd. ( "Life Molecular" ) , a subsidiary of Life Healthcare Group Holdings ...
Why Is Lantheus Stock Trading Lower On Wednesday? - Lantheus Holdings ( NASDAQ:LNTH )
CMS proposes a $140 packaging threshold for drugs and biologicals in CY 2026. Diagnostic radiopharmaceuticals threshold is proposed at $655, up from $630 in CY 2025. PPI and Industrial Production drop Wednesday morning - see how Matt Maley is trading the reaction, live at 6 PM ET.
What Does the Market Think About Lantheus Holdings? - Lantheus Holdings ( NASDAQ:LNTH )
Lantheus Holdings's LNTH short percent of float has risen 14.21% since its last report. The company recently reported that it has 9.13 million shares sold short, which is 17.36% of all regular shares that are available for trading.
Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging ( SNMMI ) Annual Meeting
BEDFORD, Mass., June 11, 2025 ( GLOBE NEWSWIRE ) -- Lantheus Holdings, Inc. ( the Company ) ( NASDAQ: LNTH ) , the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced the presentation of new ...
Perspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2025 Results
SEATTLE, May 12, 2025 ( GLOBE NEWSWIRE ) -- Perspective Therapeutics, Inc. ( "Perspective," the "Company," "we," "us," and "our" ) ( NYSE AMERICAN: CATX ) , a radiopharmaceutical company that is pioneering advanced treatments for cancers throughout the body, today provided a business update and ...
Should Invesco S&P MidCap 400 GARP ETF ( GRPM ) Be on Your Investing Radar?
Style Box ETF report for ...
Sarepta Therapeutics, Mercury Systems, Arista Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Arista Networks ( NYSE:ANET ) , Apellis Pharmaceuticals ( NASDAQ:APLS )
U.S. stock futures were higher this morning, with the Dow futures gaining over 300 points on Wednesday. Shares of Sarepta Therapeutics, Inc. SRPT fell sharply in today's pre-market trading after the company reported a first-quarter adjusted EPS miss.
Lantheus Announces Sale of SPECT Business to SHINE Technologies - Lantheus Holdings ( NASDAQ:LNTH )
Enables Lantheus to focus on innovative radiopharmaceuticals, while maximizing the value of its SPECT business SHINE will acquire products TechneLite®, NEUROLITE®, Xenon Xe-133 Gas, and Cardiolite®
Is Invesco S&P MidCap 400 GARP ETF ( GRPM ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Contrast Media Market is expected to generate a revenue of USD 6.8 Billion by 2031, Globally, at 2.59% CAGR: Verified Market Research®
Lewes, Delaware, April 25, 2025 ( GLOBE NEWSWIRE ) -- The Global Contrast Media Market Size is projected to grow at a CAGR of 2.59% from 2024 to 2031, according to a new report published by Verified Market Research®.
NurExone Appoints Biotech Industry Leader - Jacob Licht to Lead U.S. Operations and Exo-Top Manufacturing Expansion and Completes Continuance into Ontario - NurExone Biologic ( OTC:NRXBF )
TORONTO and HAIFA, Israel, April 22, 2025 ( GLOBE NEWSWIRE ) -- NurExone Biologic Inc.
Lantheus Completes Acquisition of Evergreen Theragnostics - Lantheus Holdings ( NASDAQ:LNTH )
BEDFORD, Mass., April 01, 2025 ( GLOBE NEWSWIRE ) -- Lantheus Holdings, Inc. ( "Lantheus" or the "Company" ) LNTH, the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced that it has ...
Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2024 Results
SEATTLE, March 26, 2025 ( GLOBE NEWSWIRE ) -- Perspective Therapeutics, Inc. ( "Perspective," the "Company," "we," "us," and "our" ) ( NYSE AMERICAN: CATX ) , a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today provided a ...
Here's Why You Should Hold GEHC Stock in Your Portfolio for Now
GE HealthCare's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.
Medical Imaging Reagents Market to Reach US$ 32.4 Bn by 2035, Driven by Innovations in Precision Imaging and Diagnostic Advancements | Transparency Market Research
Wilmington, Delaware, Transparency Market Research Inc. -, March 24, 2025 ( GLOBE NEWSWIRE ) -- The global medical imaging reagents market, projected to reach US$ 32.4 billion by 2035 from its 2024 valuation of US$ 19.2 billion, is advancing steadily at a CAGR of 4.8%.
3 NY Investments Mutual Funds for Solid Gains
Invest in NY Life Investments mutual funds like EPSRX, MCOAX and MLRSX for broad investment opportunities.
Should Invesco S&P MidCap 400 GARP ETF ( GRPM ) Be on Your Investing Radar?
Style Box ETF report for ...
Is Invesco S&P MidCap 400 GARP ETF ( GRPM ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Lantheus' Pylarify Hit $1B in 2024 Sales
Lantheus Holdings ( NASDAQ: LNTH ) held its fourth-quarter and full-year 2024 earnings call on Feb. 26, 2025, highlighting achievements in its radiopharmaceutical portfolio and announcing strategic transactions.Prostate imaging drug Pylarify has become the first radiodiagnostic blockbuster, ...
Workday, ACM Research, ZoomInfo Technologies, CEVA, Intuit And Other Big Stocks Moving Higher On Wednesday - ASP Isotopes ( NASDAQ:ASPI ) , ACM Research ( NASDAQ:ACMR )
U.S. stocks were mixed, with the Dow Jones falling over 150 points on Wednesday. Shares of Workday, Inc. WDAY rose sharply during Tuesday's session after the company reported better-than-expected fourth-quarter financial results.
Lantheus to Present at Upcoming Investor Conferences
BEDFORD, Mass., Feb. 21, 2025 ( GLOBE NEWSWIRE ) -- Lantheus Holdings, Inc. ( "Lantheus" ) ( NASDAQ: LNTH ) , the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced members of its ...
Lantheus to Present at Upcoming Investor Conferences - Lantheus Holdings ( NASDAQ:LNTH )
BEDFORD, Mass., Feb. 21, 2025 ( GLOBE NEWSWIRE ) -- Lantheus Holdings, Inc. ( "Lantheus" ) LNTH, the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced members of its management team ...
Lantheus Appoints Phuong Khanh ( P.K. ) Morrow, M.D., as New Board Member
BEDFORD, Mass., Jan. 30, 2025 ( GLOBE NEWSWIRE ) -- Lantheus Holdings, Inc. ( "Lantheus" ) ( NASDAQ: LNTH ) , the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced the appointment of ...
Why Lantheus Holdings Stock Got Thrashed on Tuesday
Radiopharmaceutical specialist Lantheus Holdings ( NASDAQ: LNTH ) had some news to report Tuesday morning, but the market didn't greet it warmly. Following its announcement of a fresh acquisition, investors traded out of the niche healthcare stock, leaving it with a more than 7% loss on the day.
Lantheus To Buy Evergreen Theragnostics For Over $1 Billion To Bolster Its Cancer Radiopharmaceutical Portfolio - Lantheus Holdings ( NASDAQ:LNTH )
Lantheus will acquire Evergreen Theragnostics for $250 million upfront, plus up to $752.5 million in milestone payments, closing in H2 2025. The Life Molecular Imaging acquisition adds Neuraceq to Lantheus' portfolio, establishing an Alzheimer's diagnostic franchise. On Tuesday, Lantheus ...
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader
Advances radiopharmaceutical leadership with addition of scalable manufacturing infrastructure and end-to-end clinical development capabilities ...
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader - Lantheus Holdings ( NASDAQ:LNTH )
Advances radiopharmaceutical leadership with addition of scalable manufacturing infrastructure and end-to-end clinical development capabilities Adds OCTEVY™, a registrational-stage diagnostic asset, targeting neuroendocrine tumors that is complementary to Lantheus' therapeutic agent, PNT2003
Deal Dispatch: Biden Punts TikTok Ban To Trump, Fate Hangs - Another Private Equity Owned Retailer Goes Bankrupt - AbbVie ( NYSE:ABBV ) , Biogen ( NASDAQ:BIIB )
Fabric retailer Joann joins the growing quilt ofretail casualties: Party City, Big Lots, The Body Shop and Container Store to name a few. Cleveland-Cliffs CEO Lourenco Goncalves' rhetoric at a press conference escalated tensions with US Steel and Nippon. Get Wall Street's Hottest Chart Every ...
Reasons to Add GE HealthCare Stock to Your Portfolio Now
GEHC's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.
Why Lantheus Holdings ( LNTH ) Stock Is Down 4% - Lantheus Holdings ( NASDAQ:LNTH )
Lantheus shares are trading lower by 4.4% during Monday's session. The company announced a $350 million acquisition. Get Real-Time News and Alerts for Your Portfolio Lantheus Holdings Inc LNTH shares are trading lower by 4.4% to $91.64 during Monday's session after the company announced a $350 ...
Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer's Disease Radiodiagnostic Market - Lantheus Holdings ( NASDAQ:LNTH )
Enhances Lantheus' growth profile with Neuraceq®, a globally approved F-18 PET imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer's Disease
Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer's Disease Radiodiagnostic Market
Enhances Lantheus' growth profile with Neuraceq®, a globally approved F-18 PET imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer's Disease ...
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Lantheus Holdings ( NASDAQ:LNTH )
Lantheus Holdings LNTH has outperformed the market over the past 5 years by 23.29% on an annualized basis producing an average annual return of 36.08%. Currently, Lantheus Holdings has a market capitalization of $6.19 billion.
Is Invesco S&P MidCap 400 GARP ETF ( GRPM ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Should Invesco S&P MidCap 400 GARP ETF ( GRPM ) Be on Your Investing Radar?
Style Box ETF report for ...
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday - Akso Health ( NASDAQ:AHG ) , Antero Resources ( NYSE:AR )
U.S. stocks were lower, with the Dow Jones index falling more than 700 points on Monday. Shares of Cytek Biosciences, Inc. CTKB rose sharply during Monday's session. Cytek Biosciences announced a $50 million stock buyback program for 2025. Cytek Biosciences shares jumped 6.1% to $6.78 on Monday.
Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia
SYDNEY, Dec. 30, 2024 ( GLOBE NEWSWIRE ) -- Radiopharm Theranostics ( ASX:RAD, "Radiopharm" or the "Company" ) , a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, is pleased to announce that it has ...
2 Stock Market Predictions for 2025: 2 Stocks Worth Buying No Matter What Happens
Short-term market predictions are fun, but rarely worth investing in. Here are two stocks we think will be winners no matter what happens with the market in 2025.
P/E Ratio Insights for Lantheus Holdings - Lantheus Holdings ( NASDAQ:LNTH )
In the current session, the stock is trading at $93.06, after a 0.44% spike. Over the past month, Lantheus Holdings Inc. LNTH stock increased by 7.65%, and in the past year, by 56.81%.
This Box Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - DoubleVerify Hldgs ( NYSE:DV ) , Box ( NYSE:BOX )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Goldman Sachs analyst Paul Choi initiated coverage on Lantheus Holdings, Inc.
Reasons to Retain GE HealthCare Stock in Your Portfolio Now
GEHC's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.
How Is The Market Feeling About Lantheus Holdings? - Lantheus Holdings ( NASDAQ:LNTH )
Lantheus Holdings's LNTH short percent of float has risen 6.28% since its last report. The company recently reported that it has 4.45 million shares sold short, which is 8.46% of all regular shares that are available for trading.
